Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Cir Esp ; 85(1): 45-52, 2009 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-19239937

RESUMO

INTRODUCTION: Anaemia is common in oncology patients who are going to have surgery for tumour resection. Allogenic blood transfusion has been associated with a greater incidence of postoperative complications. The aim of this study is to analyse current clinical practice as regards the preoperative treatment and conditions of these patients in Spain. MATERIAL AND METHOD: This is an epidemiological observational study which included 472 patients from different hospitals. The data included in the clinical history was analysed: tumour location, preoperative laboratory tests, functional situation (Karnofsky index [KI]), anaemia treatment and transfusions given since the diagnosis. RESULTS: As regards the tumour location, 181 were urological (38.3%), 161 digestive system (34.1%), and 130 gynaecological (27.5%). The time from the initial diagnosis until surgical intervention was 6.2+/-6 weeks, and 19.1+/-23 days from the anaesthetist visit to the surgical operation. The mean pre-operative haemoglobin (Hb) was 13.1+/-2 g/dl. The anaemia was treated in 12.9% of the patients and 15% (69 patients) received a transfusion before surgery. A total of 28.1% patients had a KI< or =80. The lowest preoperative haemoglobin levels are associated with the lowest KI. CONCLUSIONS: Anaemia is present in a high percentage of oncology patients who are going to be surgically treated. Preoperative blood transfusion is the most common treatment. It was observed that there is sufficient preoperative time to be able to improve preparation of the patient for surgery.


Assuntos
Anemia/complicações , Anemia/epidemiologia , Neoplasias/complicações , Neoplasias/cirurgia , Idoso , Anemia/terapia , Transfusão de Sangue , Estudos Transversais , Feminino , Humanos , Masculino , Cuidados Pré-Operatórios , Espanha
2.
Cir. Esp. (Ed. impr.) ; 85(1): 45-52, ene. 2009. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-59342

RESUMO

Introducción: la anemia es frecuente en el paciente oncológico que va a ser sometido a cirugía para resección tumoral. La transfusión de sangre alogénica se ha relacionado con una mayor incidencia de complicaciones postoperatorias. El objetivo de este estudio es analizarla práctica clínica actual en relación con el tratamiento y las condiciones preoperatorias de estos pacientes en nuestro medio. Material y método: se trata de un estudio observacional epidemiológico en el que se incluye a472 pacientes procedentes de distintos hospitales. Se analizan los datos incluidos en la historia clínica: localización tumoral, analítica preoperatoria, situación funcional (índice de Karnofsky [IK]), tratamiento de la anemia y transfusiones realizadas desde el diagnóstico. Resultados: Según la localización tumoral, hay 181 tumores urológicos (38,3%), 161 digestivos(34,1%) y 130 ginecológicos (27,5%). El tiempo transcurrido desde el momento del diagnóstico hasta la intervención quirúrgica fue de 6,2 ± 6 semanas, y 19,1 ± 23 días desde la consulta de preanestesia hasta la intervención quirúrgica. La hemoglobina (Hb) preoperatoria media fue 13,1 ± 2 g/dl. En el 12,9% de los pacientes se trató la anemia y un 15%(69 pacientes) recibió alguna transfusión antes de la cirugía. El 28,1% de los pacientes presentaban un IK ≤ 80. Las cifras preoperatorias de Hb más bajas se relacionan con los IK más bajos. Conclusiones: un porcentaje elevado de pacientes oncológicos que van a ser tratados quirúrgicamente tienen anemia. La transfusión de sangre preoperatoria es el tratamiento más frecuente. Se observa que hay un tiempo preoperatorio suficiente que permitiría mejorarla preparación del paciente para la intervención quirúrgica (AU)


Introduction: Anaemia is common in oncology patients who are going to have surgery for tumour resection. Allogenic blood transfusion has been associated with a greater incidence of postoperative complications. The aim of this study is to analyse current clinical practice as regards the preoperative treatment and conditions of these patients in Spain. Material and method: This is an epidemiological observational study which included 472patients from different hospitals. The data included in the clinical history was analysed: tumour location, preoperative laboratory tests, functional situation (Karnofsky index [KI]), anaemia treatment and transfusions given since the diagnosis. Results: As regards the tumour location, 181 were urological (38.3%), 161 digestive system(34.1%), and 130 gynaecological (27.5%). The time from the initial diagnosis until surgical intervention was 6.2±6 weeks, and 19.1±23 days from the anesthetist visit to the surgical operation. The mean pre-operative haemoglobin (Hb) was 13.1±2 g/dl. The anaemia was treated in 12.9% of the patients and 15% (69 patients) received a transfusion before surgery. A total of 28.1% patients had a KI≤80. The lowest preoperative (..) (AU)


Assuntos
Humanos , Masculino , Feminino , Idoso , Neoplasias Gastrointestinais/cirurgia , Neoplasias Urogenitais/cirurgia , Anemia/diagnóstico , Anemia/terapia , Estudos Prospectivos , Estudos Longitudinais , Cuidados Pré-Operatórios , Hemoglobinometria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...